Drugs targeting adenosine signaling pathways: A current view
In conclusion, targeting purinergic signaling represents a great therapeutic challenge. The actual knowledge of the involvement of adenosinergic signaling as part of the mechanism of action of old drugs has open a path not only for drug-repurposing but also for new therapeutic strategies.PMID:37506580 | DOI:10.1016/j.biopha.2023.115184
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Barbara Kutryb-Zaj ąc Ada Kawecka Khrystyna Nasadiuk Alicja Braczko Klaudia Stawarska Elisabetta Caiazzo Patrycja Kosza łka Carla Cicala Source Type: research
More News: Arthritis | Asthma | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Drugs & Pharmacology | Heart | Lexiscan | Rheumatoid Arthritis | Rheumatology